Casirivimab
Modify Date: 2024-01-16 19:15:35
Casirivimab structure
|
Common Name | Casirivimab | ||
|---|---|---|---|---|
| CAS Number | 2415933-42-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CasirivimabCasirivimab (REGN10933) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), it reduces viral load and improves diseases[1]. |
| Name | Casirivimab |
|---|
| Description | Casirivimab (REGN10933) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), it reduces viral load and improves diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
SARS-CoV-2[1] |
| References |
| No Any Chemical & Physical Properties |